Protein kinase C inhibitors for immune disorders
- PMID: 24892801
- PMCID: PMC4138286
- DOI: 10.1016/j.drudis.2014.05.008
Protein kinase C inhibitors for immune disorders
Abstract
Protein kinase C (PKC) proteins are a group of well-conserved, intracellular signaling enzymes expressed in all cells and tissues, including immune cells. Much of the molecular insight into PKC immunobiology has been gleaned from studies using PKC gene (Prkc) knockout mice and the analysis of different disease models in these animals. More-recent studies have revealed that PKCs also have crucial roles in the pathogenesis of human immune disorders. Therefore, strategies to modulate the functions of PKC enzymes could have a major impact on the treatment and therapies of autoimmune diseases and other immune disorders.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Similar articles
-
PKC inhibitors: potential in T cell-dependent immune diseases.Curr Opin Cell Biol. 2009 Apr;21(2):262-7. doi: 10.1016/j.ceb.2008.12.008. Epub 2009 Feb 3. Curr Opin Cell Biol. 2009. PMID: 19195860 Review.
-
Protein kinase C isozymes as potential therapeutic targets in immune disorders.Expert Opin Ther Targets. 2008 May;12(5):535-52. doi: 10.1517/14728222.12.5.535. Expert Opin Ther Targets. 2008. PMID: 18410238 Review.
-
The arrival of JAK inhibitors: advancing the treatment of immune and hematologic disorders.BioDrugs. 2013 Oct;27(5):431-8. doi: 10.1007/s40259-013-0040-7. BioDrugs. 2013. PMID: 23743669 Free PMC article. Review.
-
Targeting protein kinase C subtypes in pancreatic cancer.Expert Rev Anticancer Ther. 2015 Apr;15(4):433-8. doi: 10.1586/14737140.2015.1003810. Epub 2015 Jan 20. Expert Rev Anticancer Ther. 2015. PMID: 25604078 Free PMC article. Review.
-
Protein kinase C inhibitors: a patent review (2008 - 2009).Expert Opin Ther Pat. 2013 Oct;23(10):1297-315. doi: 10.1517/13543776.2013.805205. Epub 2013 Jun 25. Expert Opin Ther Pat. 2013. PMID: 23795914 Review.
Cited by
-
Intracellular Delivery of Anti-pPKCθ (Thr538) via Protein Transduction Domain Mimics for Immunomodulation.Mol Ther. 2016 Dec;24(12):2118-2130. doi: 10.1038/mt.2016.177. Epub 2016 Sep 16. Mol Ther. 2016. PMID: 27633441 Free PMC article.
-
Protein kinases as switches for the function of upstream stimulatory factors: implications for tissue injury and cancer.Front Pharmacol. 2015 Feb 18;6:3. doi: 10.3389/fphar.2015.00003. eCollection 2015. Front Pharmacol. 2015. PMID: 25741280 Free PMC article.
-
Mast Cell Activation and Microtubule Organization Are Modulated by Miltefosine Through Protein Kinase C Inhibition.Front Immunol. 2018 Jul 9;9:1563. doi: 10.3389/fimmu.2018.01563. eCollection 2018. Front Immunol. 2018. PMID: 30038620 Free PMC article.
-
Utilizing Nanopore direct RNA sequencing of blood from patients with sepsis for discovery of co- and post-transcriptional disease biomarkers.BMC Infect Dis. 2025 May 13;25(1):692. doi: 10.1186/s12879-025-11078-z. BMC Infect Dis. 2025. PMID: 40355874 Free PMC article.
-
Protein kinase C in the immune system: from signalling to chromatin regulation.Immunology. 2015 Dec;146(4):508-22. doi: 10.1111/imm.12510. Epub 2015 Oct 6. Immunology. 2015. PMID: 26194700 Free PMC article. Review.
References
-
- Soloff RS, et al. Targeted deletion of protein kinase C lambda reveals a distribution of functions between the two atypical protein kinase C isoforms. J. Immunol. 2004;173:3250–3260. - PubMed
-
- Pfeifhofer C, et al. Defective IgG2a/2b class switching in PKC alpha−/− mice. J. Immunol. 2006;176:6004–6011. - PubMed
-
- Su TT, et al. PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 2002;3:780–786. - PubMed
-
- Miyamoto A, et al. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature. 2002;416:865–869. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical